RELX Backs 2018 View After Nine-Month Underlying Revenue Rose 4%
October 25 2018 - 2:40AM
Dow Jones News
By Adria Calatayud
RELX PLC (REL.LN) confirmed Thursday its full-year guidance
after posting a 4% increase in underlying revenue for the first
nine months.
The Anglo-Dutch professional-information and events group said
it continues to anticipate 2018 to be a year of underlying growth
in revenue and in adjusted operating profit, together with growth
in adjusted earnings per share on a constant-currency basis.
The company behind medical journal the Lancet and the London
Book Fair said it invested 943 million pounds ($1.22 billion) in
seven acquisitions in 2018 to date and sold four assets worth GBP28
million.
For the first nine months, underlying revenue grew 2% at RELX's
scientific, technical and medical division--the company's largest
segment--as well as 8% in risk and business analytics, 2% in legal
and 6% in its exhibitions unit.
RELX said that to date, it has completed share buybacks worth
GBP650 million of the previously announced GBP700 million and plans
to deploy the remainder by year end.
The company's simplification of its corporate structure into a
single parent company was completed on Sept. 8, RELX said.
Write to Adria Calatayud at
adria.calatayudvaello@dowjones.com
(END) Dow Jones Newswires
October 25, 2018 02:25 ET (06:25 GMT)
Copyright (c) 2018 Dow Jones & Company, Inc.
RELX (EU:REN)
Historical Stock Chart
From Mar 2024 to Apr 2024
RELX (EU:REN)
Historical Stock Chart
From Apr 2023 to Apr 2024